GMED
Globus Medical Inc - Class A (GMED)
Healthcare • NYSE • $77.95-8.37%
- Symbol
- GMED
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $77.95
- Daily Change
- -8.37%
- Market Cap
- $10.58B
- Trailing P/E
- 18.21
- Forward P/E
- 15.23
- 52W High
- $101.40
- 52W Low
- $51.79
- Analyst Target
- $111.50
- Dividend Yield
- N/A
- Beta
- 1.00
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; …
Company websiteResearch GMED on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.